Authentification abonné
lvrea
Accueil Tous les numéros Volume 27 / Numéro 2 (Mars 2018) Méd. Intensive Réa., 27 2 (2018) 97-113 Références
Accès gratuit
Numéro
Méd. Intensive Réa.
Volume 27, Numéro 2, Mars 2018
Cardiovasculaire
Page(s) 97 - 113
Section Mise au point / Update
DOI https://doi.org/10.3166/rea-2018-0023
Publié en ligne 10 mai 2018
  • Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH, (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341: 625–634 [CrossRef] [PubMed] [Google Scholar]
  • Reynolds HR, Hochman JS, (2008) Cardiogenic shock: current concepts and improving outcomes. Circulation 117: 686–697 [CrossRef] [PubMed] [Google Scholar]
  • Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37: 2129–2200 [CrossRef] [PubMed] [Google Scholar]
  • Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, Webb JG, Steingart R, Picard MH, Menegus MA, Boland J, Sanborn T, Buller CE, Modur S, Forman R, Desvigne-Nickens P, Jacobs AK, Slater JN, LeJemtel TH, (2001) One-year survival following early revascularization for cardiogenic shock. JAMA 285: 190–192 [CrossRef] [PubMed] [Google Scholar]
  • Kohsaka S, Menon V, Lowe AM, Lange M, Dzavik V, Sleeper LA, Hochman JS, (2005) Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 165: 1643–1650 [CrossRef] [PubMed] [Google Scholar]
  • Hochman JS, (2003) Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107: 2998–3002 [CrossRef] [PubMed] [Google Scholar]
  • Aissaoui N, Puymirat E, Tabone X, Charbonnier B, Schiele F, Lefevre T, Durand E, Blanchard D, Simon T, Cambou JP, Danchin N, (2012) Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. Eur Heart J 33: 2535–2543 [CrossRef] [PubMed] [Google Scholar]
  • Reyentovich A, Barghash MH, Hochman JS, (2016) Management of refractory cardiogenic shock. Nat Rev Cardiol 13: 481–492 [Google Scholar]
  • Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J, (2009) Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 119: 1211–1219 [CrossRef] [PubMed] [Google Scholar]
  • Thiele H, Allam B, Chatellier G, Schuler G, Lafont A, (2010) Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J 31: 1828–1835 [CrossRef] [PubMed] [Google Scholar]
  • Jeger RV, Radovanovic D, Hunziker PR, Pfisterer ME, Stauffer JC, Erne P, Urban P, (2008) Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med 149: 618–626 [CrossRef] [PubMed] [Google Scholar]
  • Puymirat E, Fagon JY, Aegerter P, Diehl JL, Monnier A, Hauw-Berlemont C, Boissier F, Chatellier G, Guidet B, Danchin N, Aissaoui N, (2016) Cardiogenic shock in intensive care units: evolution of prevalence, patient profile, management and outcomes, 1997–2012. Eur J Heart Fail 19: 192–200 [Google Scholar]
  • Kunadian V, Qiu W, Ludman P, Redwood S, Curzen N, Stables R, Gunn J, Gershlick A, (2014) Outcomes in patients with cardiogenic shock following percutaneous coronary intervention in the contemporary era: an analysis from the BCIS database (British Cardiovascular Intervention Society). JACC Cardiovasc Interv 7: 1374–1385 [CrossRef] [PubMed] [Google Scholar]
  • Aissaoui N, Puymirat E, Simon T, Bonnefoy-Cudraz E, Angoulvant D, Schiele F, Benamer H, Quandalle P, Prunier F, Durand E, Berard L, Blanchard D, Danchin N, (2014) Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) Registry. Crit Care 18: 516 [CrossRef] [PubMed] [Google Scholar]
  • Levy B, Bastien O, Karim B, Cariou A, Chouihed T, Combes A, Mebazaa A, Megarbane B, Plaisance P, Ouattara A, Spaulding C, Teboul JL, Vanhuyse F, Boulain T, Kuteifan K, (2015) Experts' recommendations for the management of adult patients with cardiogenic shock. Ann Intensive Care 5: 52 [Google Scholar]
  • Dzavik V, Sleeper LA, Cocke TP, Moscucci M, Saucedo J, Hosat S, Jiang X, Slater J, LeJemtel T, Hochman JS, (2003) Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 24: 828–837 [CrossRef] [PubMed] [Google Scholar]
  • Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, (2014) 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35: 2541–2619 [CrossRef] [PubMed] [Google Scholar]
  • Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C, (2016) 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 134: e282–293 [CrossRef] [PubMed] [Google Scholar]
  • Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128: e240–327 [CrossRef] [PubMed] [Google Scholar]
  • Bangalore S, Gupta N, Guo Y, Lala A, Balsam L, Roswell RO, Reyentovich A, Hochman JS, (2015) Outcomes with invasive vs conservative management of cardiogenic shock complicating acute myocardial infarction. Am J Med 128: 601–608 [Google Scholar]
  • McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33: 1787–1847 [CrossRef] [PubMed] [Google Scholar]
  • De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL, (2010) Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 362: 779–789 [CrossRef] [PubMed] [Google Scholar]
  • Levy B, Perez P, Perny J, Thivilier C, Gerard A, (2010) Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Crit Care Med 39: 450–455 [Google Scholar]
  • Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Poder P, Kivikko M, (2007) Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 297: 1883–1891 [CrossRef] [PubMed] [Google Scholar]
  • O'Connor CM, Gattis WA, Uretsky BF, Adams KF Jr, McNulty SE, Grossman SH, McKenna WJ, Zannad F, Swedberg K, Gheorghiade M, Califf RM, (1999) Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 138: 78–86 [CrossRef] [PubMed] [Google Scholar]
  • Kapur NK, Zisa DC, (2016) Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) fails to solve the haemodynamic support equation in cardiogenic shock. EuroIntervention 11: 1337–1339 [Google Scholar]
  • Vitarelli A, Terzano C, (2009) Do we have two hearts? New insights in right ventricular function supported by myocardial imaging echocardiography. Heart Fail Rev 15: 39–61 [Google Scholar]
  • Gass A, Palaniswamy C, Aronow WS, Kolte D, Khera S, Ahmad H, Cuomo LJ, Timmermans R, Cohen M, Tang GH, Kai M, Lansman SL, Lanier GM, Malekan R, Panza JA, Spielvogel D, (2014) Peripheral venoarterial extracorporeal membrane oxygenation in combination with intra-aortic balloon counterpulsation in patients with cardiovascular compromise. Cardiology 129: 137–143 [Google Scholar]
  • Petroni T, Harrois A, Amour J, Lebreton G, Brechot N, Tanaka S, Luyt CE, Trouillet JL, Chastre J, Leprince P, Duranteau J, Combes A, (2014) Intra-aortic balloon pump effects on macrocirculation and microcirculation in cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation*. Crit Care Med 42: 2075–2082 [CrossRef] [PubMed] [Google Scholar]
  • Cheng R, Hachamovitch R, Makkar R, Ramzy D, Moriguchi JD, Arabia FA, Esmailian F, Azarbal B, (2015) Lack of survival benefit found with use of intraaortic balloon pump in extracorporeal membrane oxygenation: a pooled experience of 1517 patients. J Invasive Cardiol 27: 453–458 [Google Scholar]
  • Karatolios K, Chatzis G, Markus B, Luesebrink U, Richter A, Schieffer B, (2016) Biventricular unloading in patients with refractory cardiogenic shock. Int J Cardiol 222: 247–252 [CrossRef] [PubMed] [Google Scholar]
  • Pappalardo F, Schulte C, Pieri M, Schrage B, Contri R, Soeffker G, Greco T, Lembo R, Mullerleile K, Colombo A, Sydow K, De Bonis M, Wagner F, Reichenspurner H, Blankenberg S, Zangrillo A, Westermann D, (2017) Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail 19: 404–412 [CrossRef] [PubMed] [Google Scholar]
  • Lorusso R, (2017) Are two crutches better than one? The ongoing dilemma on the effects and need for left ventricular unloading during veno-arterial extracorporeal membrane oxygenation. Eur J Heart Fail 19: 413–415 [CrossRef] [PubMed] [Google Scholar]
  • Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Leger P, Pavie A, Chastre J, (2008) Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 36: 1404–1411 [CrossRef] [PubMed] [Google Scholar]
  • Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, Esmailian F, Azarbal B, (2014) Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg 97: 610–616 [Google Scholar]
  • Carroll BJ, Shah RV, Murthy V, McCullough SA, Reza N, Thomas SS, Song TH, Newton-Cheh CH, Camuso JM, MacGillivray T, Sundt TM, Semigran MJ, Lewis GD, Baker JN, Garcia JP, (2015) Clinical Features and outcomes in adults with cardiogenic shock supported by extracorporeal membrane oxygenation. Am J Cardiol 116: 1624–1630 [CrossRef] [PubMed] [Google Scholar]
  • de Waha S, Fuernau G, Desch S, Eitel I, Wiedau A, Lurz P, Schuler G, Thiele H, (2016) Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort. EuroIntervention 11: 1363–1371 [Google Scholar]
  • Burrell AJ, Pellegrino VA, Wolfe R, Wong WK, Cooper DJ, Kaye DM, Pilcher DV, (2015) Long-term survival of adults with cardiogenic shock after venoarterial extracorporeal membrane oxygenation. J Crit Care 30: 949–956 [Google Scholar]
  • Kim H, Lim SH, Hong J, Hong YS, Lee CJ, Jung JH, Yu S, (2012) Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock. Resuscitation 83: 971–975 [CrossRef] [PubMed] [Google Scholar]
  • Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, Esmailian F, Azarbal B, (2014) Clinical outcomes in fulminant myocarditis requiring extracorporeal membrane oxygenation: a weighted meta-analysis of 170 patients. J Card Fail 20: 400–406 [CrossRef] [PubMed] [Google Scholar]
  • Mirabel M, Luyt CE, Leprince P, Trouillet JL, Leger P, Pavie A, Chastre J, Combes A, (2011) Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med 39: 1029–1035 [CrossRef] [PubMed] [Google Scholar]
  • Doll N, Fabricius A, Borger MA, Bucerius J, Doll S, Kramer K, Ullmann C, Schmitt DV, Walther T, Falk V, Mohr FW, (2003) Temporary extracorporeal membrane oxygenation in patients with refractory postoperative cardiogenic shock-a single center experience. J Card Surg 18: 512–518 [CrossRef] [PubMed] [Google Scholar]
  • Masson R, Colas V, Parienti JJ, Lehoux P, Massetti M, Charbonneau P, Saulnier F, Daubin C, (2012) A comparison of survival with and without extracorporeal life support treatment for severe poisoning due to drug intoxication. Resuscitation 83: 1413–1417 [Google Scholar]
  • de Lange DW, Sikma MA, Meulenbelt J, (2013) Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clin Toxicol (Phila) 51: 385–393 [CrossRef] [PubMed] [Google Scholar]
  • Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ, Vis MM, Wykrzykowska JJ, Koch KT, Baan J, de Winter RJ, Piek JJ, Lagrand WK, de Mol BA, Tijssen JG, Henriques JP, (2017) Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 69: 278–287 [CrossRef] [PubMed] [Google Scholar]
  • Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, Russ M, Schlitt A, Buerke U, Christoph A, Schmidt H, Winkler M, Thiery J, Werdan K, Buerke M, (2009) Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 38: 152–160 [Google Scholar]
  • Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Bohm M, Ebelt H, Schneider S, Schuler G, Werdan K, (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367: 1287–1296 [CrossRef] [PubMed] [Google Scholar]
  • Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Bohm M, Ebelt H, Schneider S, Werdan K, Schuler G, (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382: 1638–1645 [CrossRef] [PubMed] [Google Scholar]
  • Ahmad Y, Sen S, Shun-Shin MJ, Ouyang J, Finegold JA, Al-Lamee RK, Davies JE, Cole GD, Francis DP, (2015) Intra-aortic balloon pump therapy for acute myocardial infarction: a meta-analysis. JAMA Intern Med 175: 931–939 [CrossRef] [PubMed] [Google Scholar]
  • Sjauw KD, Engstrom AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP, (2009) A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 30: 459–468 [CrossRef] [PubMed] [Google Scholar]
  • Sauren LD, Accord RE, Hamzeh K, de Jong M, van der Nagel T, van der Veen FH, Maessen JG, (2007) Combined Impella® and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: an experimental study. Artif Organs 31: 839–842 [CrossRef] [PubMed] [Google Scholar]
  • Meyns B, Stolinski J, Leunens V, Verbeken E, Flameng W, (2003) Left ventricular support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol 41: 1087–1095 [CrossRef] [PubMed] [Google Scholar]
  • Remmelink M, Sjauw KD, Henriques JP, de Winter RJ, Koch KT, van der Schaaf RJ, Vis MM, Tijssen JG, Piek JJ, Baan J Jr, (2007) Effects of left ventricular unloading by Impella® recover LP2.5 on coronary hemodynamics. Catheter Cardiovasc Interv 70: 532–537 [CrossRef] [PubMed] [Google Scholar]
  • Reesink KD, Dekker AL, Van Ommen V, Soemers C, Geskes GG, van der Veen FH, Maessen JG, (2004) Miniature intracardiac assist device provides more effective cardiac unloading and circulatory support during severe left heart failure than intraaortic balloon pumping. Chest 126: 896–902 [CrossRef] [PubMed] [Google Scholar]
  • Kawashima D, Gojo S, Nishimura T, Itoda Y, Kitahori K, Motomura N, Morota T, Murakami A, Takamoto S, Kyo S, Ono M, (2011) Left ventricular mechanical support with Impella® provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J 57: 169–176 [CrossRef] [PubMed] [Google Scholar]
  • Engstrom AE, Cocchieri R, Driessen AH, Sjauw KD, Vis MM, Baan J, de Jong M, Lagrand WK, van der Sloot JA, Tijssen JG, de Winter RJ, de Mol BA, Piek JJ, Henriques JP, (2011) The Impella® 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience. Crit Care Med 39: 2072–2079 [CrossRef] [PubMed] [Google Scholar]
  • Casassus F, Corre J, Leroux L, Chevalereau P, Fresselinat A, Seguy B, Calderon J, Coste P, Ouattara A, Roques X, Barandon L, (2015) The use of Impella® 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction. J Interv Cardiol 28: 41–50 [CrossRef] [PubMed] [Google Scholar]
  • Gaudard P, Mourad M, Eliet J, Zeroual N, Culas G, Rouviere P, Albat B, Colson P, (2015) Management and outcome of patients supported with Impella® 5.0 for refractory cardiogenic shock. Crit Care 19: 363 [CrossRef] [PubMed] [Google Scholar]
  • O'Neill WW, Schreiber T, Wohns DH, Rihal C, Naidu SS, Civitello AB, Dixon SR, Massaro JM, Maini B, Ohman EM, (2013) The current use of Impella® 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol 27: 1–11 [Google Scholar]
  • Basir MB, Schreiber TL, Grines CL, Dixon SR, Moses JW, Maini BS, Khandelwal AK, Ohman EM, O'Neill WW, (2017) Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock. Am J Cardiol 119: 845–851 [CrossRef] [PubMed] [Google Scholar]
  • Delmas C, Leurent G, Lamblin N, Bonnefoy E, Roubille F, (2017) Cardiogenic shock management: still a challenge and a need for large-registry data. Arch Cardiovasc Dis 110: 433–438 [CrossRef] [PubMed] [Google Scholar]
  • Haneya A, Philipp A, Puehler T, Rupprecht L, Kobuch R, Hilker M, Schmid C, Hirt SW, (2012) Temporary percutaneous right ventricular support using a centrifugal pump in patients with postoperative acute refractory right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac Surg 41: 219–223 [CrossRef] [PubMed] [Google Scholar]
  • Anderson MB, Goldstein J, Milano C, Morris LD, Kormos RL, Bhama J, Kapur NK, Bansal A, Garcia J, Baker JN, Silvestry S, Holman WL, Douglas PS, O'Neill W, (2015) Benefits of a novel percutaneous ventricular assist device for right heart failure: the prospective RECOVER RIGHT study of the Impella® RP device. J Heart Lung Transplant 34: 1549–1560 [Google Scholar]
  • Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, Kern M, Garratt KN, Goldstein JA, Dimas V, Tu T, (2015) 2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencionista; affirmation of value by the Canadian Association of Interventional Cardiology–Association canadienne de cardiologie d’intervention. J Am Coll Cardiol 65: 2140–2141 [CrossRef] [PubMed] [Google Scholar]
  • Doll JA, Ohman EM, Patel MR, Milano CA, Rogers JG, Wohns DH, Kapur NK, Rao SV, (2015) A team-based approach to patients in cardiogenic shock. Catheter Cardiovasc Interv 88: 424–433 [CrossRef] [PubMed] [Google Scholar]
  • Shah AP, Retzer EM, Nathan S, Paul JD, Friant J, Dill KE, Thomas JL, (2015) Clinical and economic effectiveness of percutaneous ventricular assist devices for high-risk patients undergoing percutaneous coronary intervention. J Invasive Cardiol 27: 148–154 [Google Scholar]
  • Khera R, Cram P, Vaughan-Sarrazin M, Horwitz PA, Girotra S, (2016) Use of mechanical circulatory support in percutaneous coronary intervention in the United States. Am J Cardiol 117: 10–16 [CrossRef] [PubMed] [Google Scholar]
  • Stretch R, Sauer CM, Yuh DD, Bonde P, (2014) National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol 64: 1407–1415 [CrossRef] [PubMed] [Google Scholar]
  • Van Mieghem NM, Daemen J, den Uil C, Dur O, Joziasse L, Maugenest A, Fitzgerald K, Parker C, Muller P, van Geuns RJ, (2017) Design and principle of operation of the HeartMate PHPTM (Percutaneous Heart Pump). EuroIntervention [in press] [Google Scholar]
  • den Uil CA, Daemen J, Lenzen MJ, Maugenest AM, Joziasse L, van Geuns RJ, Van Mieghem NM, (2017) Pulsatile iVAC 2L circulatory support in high-risk percutaneous coronary intervention. EuroIntervention 12: 1689–1696 [Google Scholar]
  • Kapur NK, Paruchuri V, Urbano-Morales JA, Mackey EE, Daly GH, Qiao X, Pandian N, Perides G, Karas RH, (2013) Mechanically unloading the left ventricle before coronary reperfusion reduces left ventricular wall stress and myocardial infarct size. Circulation 128: 328–336 [CrossRef] [PubMed] [Google Scholar]
  • Ouweneel DM, Henriques JP, (2012) Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations. Heart 98: 1246–1254 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.